QUOTED. 21 January 2021. Larry Biegelsen.
The recently US FDA-cleared Velys robotic-assisted system from DePuy Synthes has distinct features. It also has a small footprint that makes it well-suited for ambulatory surgery centers. See what Larry Biegelsen, an analyst with Wells Fargo, said about it here.
“We believe the clearance of Velys helps J&J level the playing field versus its competitors.” – Larry Biegelsen, analyst, Wells Fargo
Click here for a free trial of Medtech Insight